Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans.
Where this comes from
- Record sourced from PubMed, PMID 21859704.
- Also identified by DOI 10.1093/rheumatology/ker244.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Birmingham Rheumatoid Arthritis Model (BRAM) has been developed over a number of years to inform several appraisals of biologic drugs by the Technology Appraisals Committee of the UK National Institute for Health and Clinical Excellence. This article describes the processes used in the construction of the different versions of the BRAM.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Biological Products